Metabolic cooperation of ascorbic acid and glutathione in normal and vitamin C-deficient ODS rats.
Although the coordination of various antioxidants is important for the protection of organisms from oxidative stress, dynamic aspects of the interaction of endogenous antioxidants in vivo remain to be elucidated. We studied the metabolic coordination of two naturally occurring water-soluble antioxidants, ascorbic acid (AA) and reduced glutathione (GSH), in liver, kidney and plasma of control and scurvy-prone osteogenic disorder Shionogi (ODS) rats that hereditarily lack the ability to synthesize AA. When supplemented with AA, its levels in liver and kidney of ODS rats increased to similar levels of those in control rats. Hepato-renal levels of glutathione were similar with the two animal groups except for the slight increase in its hepatic levels in AA-supplemented ODS rats. Administration of L-buthionine sulfoximine (BSO), a specific inhibitor of GSH synthesis, rapidly decreased the hepato-renal levels of glutathione in a biphasic manner, a rapid phase followed by a slower phase. Kinetic analysis revealed that glutathione turnover was enhanced significantly in liver mitochondria and renal cytosol of ODS rats. Administration of BSO significantly increased AA levels in the liver and kidney of control rats but decreased them in AA-supplemented ODS rats. Kinetic analysis revealed that AA is synthesized by control rat liver by some BSO-enhanced mechanism and the de novo synthesized AA is transferred to the kidney. Such a coordination of the metabolism of GSH and AA in liver and kidney is suppressed in AA-deficient ODS rats. These and other results suggest that the metabolism of AA and GSH forms a compensatory network by which oxidative stress can be decreased.
Wang
Y
Y
Department of Biochemistry and Molecular Pathology, Osaka City University Medical School, Abeno, Japan.
Kashiba
M
M
Kasahara
E
E
Tsuchiya
M
M
Sato
E F
EF
Utsumi
K
K
Inoue
M
M
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D001205:Ascorbic Acid / Q000378:metabolism*; D001206:Ascorbic Acid Deficiency / Q000235:genetics* / Q000378:metabolism*; D001847:Bone Diseases / Q000235:genetics* / Q000378:metabolism*; D019328:Buthionine Sulfoximine / Q000494:pharmacology; D002614:Chelating Agents; D004492:Edetic Acid; D005978:Glutathione / Q000378:metabolism*; D007202:Indicators and Reagents; D007668:Kidney / Q000201:enzymology; D008099:Liver / Q000201:enzymology; D008297:Male; D010088:Oxidoreductases / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D017208:Rats, Wistar
D000963:Antimetabolites; D002614:Chelating Agents; D007202:Indicators and Reagents; D019328:Buthionine Sulfoximine; D004492:Edetic Acid; D010088:Oxidoreductases; C020666:glutathione dehydrogenase (ascorbate); D005978:Glutathione; D001205:Ascorbic Acid